These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16462826)

  • 1. The investigational new drug application--who benefits?
    Freireich EJ
    Nat Clin Pract Oncol; 2006 Feb; 3(2):62-3. PubMed ID: 16462826
    [No Abstract]   [Full Text] [Related]  

  • 2. IRBs and the new rule on research with children.
    Maloney DM
    Hum Res Rep; 2002 Jan; 17(1):4. PubMed ID: 16270437
    [No Abstract]   [Full Text] [Related]  

  • 3. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

  • 4. Data from human research projects will now be available to public.
    Maloney DM
    Hum Res Rep; 2001 Apr; 16(4):1-2. PubMed ID: 11883453
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality-improvement research and informed consent.
    Miller FG; Emanuel EJ
    N Engl J Med; 2008 Feb; 358(8):765-7. PubMed ID: 18287598
    [No Abstract]   [Full Text] [Related]  

  • 6. Rethinking the randomized clinical trial: the 21st century application of Freireich's laws. [An interview with Emil J Freireich by H&O].
    Freireich EJ
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):801-4. PubMed ID: 19194362
    [No Abstract]   [Full Text] [Related]  

  • 7. Children as research subjects: guinea pigs or therapeutic orphans?
    Tauer C
    Bioeth Exam; 2003; 7(2):1-2, 4-5. PubMed ID: 15025108
    [No Abstract]   [Full Text] [Related]  

  • 8. The globalization of clinical trials: a growing challenge in protecting human subjects: executive summary (2001).
    Department of Health and Human Services, Office of the Inspector General, USA
    J Int Bioethique; 2003; 14(1-2):165-9. PubMed ID: 15035253
    [No Abstract]   [Full Text] [Related]  

  • 9. New recommendations for protecting children as human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Nov; 19(11):1-2. PubMed ID: 15675086
    [No Abstract]   [Full Text] [Related]  

  • 10. Why not just say yes? American ethics boards are nervous about approving street drugs for use in research. Their concerns are more about politics than safety.
    Kleiner K
    New Sci; 2003 Aug; 179(2407):26. PubMed ID: 14686417
    [No Abstract]   [Full Text] [Related]  

  • 11. Agency proposes to combat "IRB shopping" with a new regulation.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):1-2. PubMed ID: 12374178
    [No Abstract]   [Full Text] [Related]  

  • 12. U.S. regulators suspend medical studies at 2 universities.
    Brainard J; Miller DW
    Chron High Educ; 2000 Feb; 96(22):A30. PubMed ID: 15744908
    [No Abstract]   [Full Text] [Related]  

  • 13. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional review boards and approval of new products without human subjects research.
    Maloney DM
    Hum Res Rep; 2002 Jul; 17(7):1-2. PubMed ID: 12731489
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating human gene therapy: legislative overreaction to human subject protection failures.
    Leavitt WJ
    Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905
    [No Abstract]   [Full Text] [Related]  

  • 16. Agencies said to be slow on research protections reform.
    Maloney DM
    Hum Res Rep; 2001 Jul; 16(7):3. PubMed ID: 11933954
    [No Abstract]   [Full Text] [Related]  

  • 17. The basics of human subjects protection.
    Yoder LH
    Medsurg Nurs; 2006 Apr; 15(2):95-8; quiz 99. PubMed ID: 16700248
    [No Abstract]   [Full Text] [Related]  

  • 18. Spate of suspensions of academic research spurs questions about federal strategy: a U.S. agency, its own future uncertain, unsettles college officials with its crackdown.
    Brainard J
    Chron High Educ; 2000 Feb; 96(22):A29-30, A32. PubMed ID: 15744907
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulations, ethics, and research with children.
    Maloney DM
    Hum Res Rep; 2004 Apr; 19(4):3. PubMed ID: 15462033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.